Bottom line
SHSSX vs LYFIX: the short answer
SHSSX (Blackrock Health Sciences Opportunities Portfolio) and LYFIX (AlphaCentric Life Sciences and Healthcare Fund) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.
But SHSSX is far broader, holding 155 positions to 62 for LYFIX, so beyond the top names it adds exposure LYFIX doesn't have.
SHSSX is cheaper at 0.86% vs 1.41% — a difference of $55 a year per $10,000 invested.
Over five years, SHSSX returned +5.9% a year vs +5.6% for LYFIX.
Updated Nov 19, 2026
SHSSX vs LYFIX side by side
| SHSSX | LYFIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | BlackRock | Mutual |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.86% | 1.41% |
| Annual cost per $10k | $86 | $141 |
| 10-yr cost on $10k (prospectus) | $1,061 | $2,357 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +16.3% | +28.2% |
| 5-yr return (annualized) | +5.9% | +5.6% |
| 10-yr return (annualized) | +9.8% | — |
| Best quarter | — | +27.5% |
| Worst quarter | — | −11.9% |
| Net assets (fund) | $5.9B | $46.6M |
| Number of holdings | 155 | 62 |
| Portfolio turnover | 49% | 107% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
6 of SHSSX's top 25 holdings also appear in LYFIX's top 25.
| Holding | SHSSX | LYFIX |
|---|---|---|
| Gilead Sciences Inc | 4.19% | 5.53% |
| Abbvie Inc | 3.94% | 1.95% |
| Amgen Inc | 3.37% | 1.83% |
| Vertex Pharmaceuticals Inc | 2.74% | 5.33% |
| Argenx Se | 1.26% | 3.59% |
| Biogen Inc | 1.21% | 1.80% |
Source: SEC Form N-PORT
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
LYFIX top 10
- Gilead Sciences Inc — 5.53%
- Vertex Pharmaceuticals Inc — 5.33%
- Astrazeneca Plc — 4.63%
- First American Funds Inc — 4.26%
- Roivant Sciences Ltd — 3.67%
- Argenx Se — 3.59%
- Neurocrine Biosciences Inc — 3.51%
- Incyte Corp — 3.51%
- Axsome Therapeutics Inc — 3.43%
- Apogee Therapeutics Inc — 3.28%
FAQ
What is the difference between SHSSX and LYFIX?
Which is cheaper, SHSSX or LYFIX?
Should I own both SHSSX and LYFIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.